Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard S., Freedman, R. (1998). Schizophrenia, sensory gating and nicotinic receptors . Schizophrenia Bulletin, 24(2), 189-202 .
2.
American Psychiatric Association. (1996). Practice guidelines for the treatment of patients with nicotine dependence. Washington, DC: Author .
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., rev.). Washington, DC: Author .
4.
Balfour, D. J., & Fagerstrom, K. O. (1996). Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders . Pharmacology Therapeutics, 72, 51-81 .
5.
Biesalski, H. K., de Mesquita, B. B., Chesson, A., Chytil, F., Grimble, R., Hermus, R. J., Kohrle, J., Lotan, R., Norpotha, K., Pastorino, U., & Thurnham, D. (1998). European consensus statement on lung cancer: Risk factors and prevention . Lung Cancer Panel. CA: A Cancer Journal for Clinicians, 48, 167-176 .
6.
Cardoni, A. (2000). Psychotropic drug interactions 2000: Mechanisms and implications for clinical practice. New Haven, CT: Yale University School of Nursing, Neuropsychopharmacology , lecture, Nov 15.
7.
Centers for Disease Control and Prevention. (1993a). Smoking attributable mortality and years of potential life lost—United States . Morbidity and Mortality Weekly Report, 42, 645-648 .
8.
Centers for Disease Control and Prevention. (1993b). Mortality trends for selected smoking-related cancers and breast cancer—United States 1950-1990 . Morbidity and Mortality Weekly Report, 42(44), 857, 863-866 .
9.
Centers for Disease Control and Prevention. (1999). State-specific prevalence of current cigarette and cigar smoking among adults—United States, 1998 . Morbidity and Mortality Weekly Report, 48(45), 1034-1039 .
10.
Crews, C., Batal, H., Elasy, T., Casper, E., & Mehler, P. S. (1998). Primary care for those with severe and persistent mental illness . Western Journal of Medicine, 169(4), 245-250 .
11.
A clinical practice guideline for treating tobacco use and dependence: A U.S. Public Health Service report . The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. (2000). Journal of the American Medical Association, 283, 3244-3254 .
12.
Fiore, M. C., Bailey, W. C., & Cohen, S. J. (1996). Smoking cessation clinical practice guideline No. 18 (AHCPR Publication No. 96-0690). Rockville, MD: U.S. Department of Health and Human Services .
13.
Fiore, M. C., Bailey W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., et al. (2000). Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service .
14.
Glassman, A. H. (1993). Cigarette smoking: Implications for psychiatric illness . American Journal of Psychiatry, 150, 546-553 .
15.
Gourlay, S. (1994). A placebo-controlled study of three clonidine doses for smoking cessation . Clinical Pharmacology and Therapeutics, 55, 64-69 .
16.
Higgins, M. W., Enright, P. L., Kronmal, R. A., Schenker, M. B., Anton-Culver, H., & Lyles, M. (1993). Smoking and lung function in elderly men and women . Journal of the American Medical Association, 269, 2741-2748 .
17.
Hurt, R. D., Sachs, D. P., Glover, E. D., Orford, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T., Sullivan, P. M. (1997). Comparison of sustained-release bupropion and placebo for smoking cessation . New England Journal of Medicine, 337(17), 1195-1202 .
18.
Jacobs, D. R., Adachi, H., Mulder, I., Kromhout, D., Menotti, A., Nissinen, A., Blackburn, H. (1999). Cigarette smoking and mortality risk: Twenty-five year follow-up of the Seven Countries Study . Archives of Internal Medicine, 159(7), 733-740 .
19.
Kawachi, I., Coditz, G. A., & Stampfer, M. J. (1994). Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women . Archives of Internal Medicine, 154, 169-175 .
20.
Kendrick, J. S. & Merritt, R. K. (1996). Women and smoking: An update for the 1990s . American Journal of Obstetrics and Gynecology, 175, 528-535 .
21.
Lyon, E. R. (1999). A review of the effects of nicotine on schizophrenia and antipsychotic medications . Psychiatric Services, 50(10), 1346-1350 .
22.
Pomerleau, O. F. (1997). Nicotine dependence. In C. T. Bolliger & K. O. Fagerstrom (Eds.), The tobacco epidemic (Vol. 28, pp. 122-131). New York: Karger .
23.
Skogh, E., Bengtsson, F., & Nordin, C. (1999). Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report . Therapeutic Drug Monitoring, 21(5), 580-582 .
24.
U.S. Department of Health and Human Services (1994). Tobacco use among young people: A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office on Smoking and Health .
25.
World Health Organization. (1999). Combating the tobacco epidemic. In The World Health report 1999—Making a difference. Geneva: Author .
26.
Wyser, C., & Bolliger, C. T. (1997). Smoking-related disorders. In C. T. Bolliger & K. O. Fagerstrom (Eds.), The tobacco epidemic (Vol. 28, pp. 78-106). New York: Karger .
27.
Ziedonis, D. M. & George, T. P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues . Schizophrenia Bulletin, 23(2), 247-254 .
28.
Ziedonis, D. M., Wyatt, S. A., & George, T. P. (1998). Current issues in nicotine dependence and treatment. In E. F. McCance-Katz & T. Kosten (Eds.), New treatments for chemical addictions. Washington, DC: American Psychiatric Association .
